➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Mallinckrodt
Johnson and Johnson
McKesson
Baxter

Last Updated: September 16, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NATAMYCIN

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Natamycin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00516399 ↗ A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine Terminated Los Angeles Biomedical Research Institute Phase 3 2008-03-01 The purpose of this study is to determine the effectiveness of 1.25% povidone-iodine ophthalmic solution for the treatment of small to medium sized fungal corneal ulcers compared with an antifungal antibiotic.
NCT00516399 ↗ A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine Terminated University of California, Los Angeles Phase 3 2008-03-01 The purpose of this study is to determine the effectiveness of 1.25% povidone-iodine ophthalmic solution for the treatment of small to medium sized fungal corneal ulcers compared with an antifungal antibiotic.
NCT00557362 ↗ Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer Completed Aravind Eye Hospitals, India Phase 1/Phase 2 2007-11-01 We evaluated whether voriconazole is a superior treatment to natamycin for filamentous fungal keratitis in a randomized, masked, controlled trial. This is a therapeutic exploratory study to investigate the safety and feasibility of conducting a larger study and to generate preliminary data.
NCT00557362 ↗ Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer Completed Dartmouth-Hitchcock Medical Center Phase 1/Phase 2 2007-11-01 We evaluated whether voriconazole is a superior treatment to natamycin for filamentous fungal keratitis in a randomized, masked, controlled trial. This is a therapeutic exploratory study to investigate the safety and feasibility of conducting a larger study and to generate preliminary data.
NCT00557362 ↗ Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer Completed That Man May See, Inc. Phase 1/Phase 2 2007-11-01 We evaluated whether voriconazole is a superior treatment to natamycin for filamentous fungal keratitis in a randomized, masked, controlled trial. This is a therapeutic exploratory study to investigate the safety and feasibility of conducting a larger study and to generate preliminary data.
NCT00557362 ↗ Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer Completed University of California, San Francisco Phase 1/Phase 2 2007-11-01 We evaluated whether voriconazole is a superior treatment to natamycin for filamentous fungal keratitis in a randomized, masked, controlled trial. This is a therapeutic exploratory study to investigate the safety and feasibility of conducting a larger study and to generate preliminary data.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Natamycin

Condition Name

Condition Name for Natamycin
Intervention Trials
Fungal Keratitis 3
Corneal Ulcer 3
Eye Infections, Fungal 2
Infection, Fungal 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Natamycin
Intervention Trials
Keratitis 4
Corneal Ulcer 4
Ulcer 3
Mycoses 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Natamycin

Trials by Country

Trials by Country for Natamycin
Location Trials
India 5
United States 3
Nepal 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Natamycin
Location Trials
California 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Natamycin

Clinical Trial Phase

Clinical Trial Phase for Natamycin
Clinical Trial Phase Trials
Phase 3 4
Phase 2/Phase 3 1
Phase 1/Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Natamycin
Clinical Trial Phase Trials
Completed 2
Enrolling by invitation 1
Recruiting 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Natamycin

Sponsor Name

Sponsor Name for Natamycin
Sponsor Trials
University of California, San Francisco 4
Aravind Eye Hospitals, India 4
Dartmouth-Hitchcock Medical Center 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Natamycin
Sponsor Trials
Other 17
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Medtronic
AstraZeneca
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.